These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7981176)

  • 1. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
    Maggi E; Chiesa R; Melissano G; Castellano R; Astore D; Grossi A; Finardi G; Bellomo G
    Arterioscler Thromb; 1994 Dec; 14(12):1892-9. PubMed ID: 7981176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis.
    Maggi E; Bellazzi R; Gazo A; Seccia M; Bellomo G
    Kidney Int; 1994 Sep; 46(3):869-76. PubMed ID: 7996809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of biological markers of high-risk carotid artery atherosclerotic plaque: enhanced LDL oxidation.
    Chiesa R; Melissano G; Castellano R; Astore D; Marone EM; Grossi A; Maggi E; Finardi G; Casasco A; Bellomo G
    Ann Vasc Surg; 1998 Jan; 12(1):1-9. PubMed ID: 9451989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities.
    Iribarren C; Folsom AR; Jacobs DR; Gross MD; Belcher JD; Eckfeldt JH
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1171-7. PubMed ID: 9194770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.
    Bellomo G; Maggi E; Poli M; Agosta FG; Bollati P; Finardi G
    Diabetes; 1995 Jan; 44(1):60-6. PubMed ID: 7813815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.
    Uusitupa MI; Niskanen L; Luoma J; Vilja P; Mercuri M; Rauramaa R; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1236-42. PubMed ID: 8857919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation.
    Wen Y; Killalea S; Norris LA; Cooke T; Feely J
    Eur J Clin Invest; 1999 Dec; 29(12):1027-34. PubMed ID: 10583450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension.
    Marchesi E; Martignoni A; Salvini M; Catalano O; Maggi E; Negro C; Traversa B; Bellomo G
    J Hum Hypertens; 1996 Sep; 10(9):577-82. PubMed ID: 8953201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody against oxidised LDL and progression of carotid atherosclerosis.
    Salonen JT; Ylä-Herttuala S; Yamamoto R; Butler S; Korpela H; Salonen R; Nyyssönen K; Palinski W; Witztum JL
    Lancet; 1992 Apr; 339(8798):883-7. PubMed ID: 1348295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?
    Maggi E; Bellazzi R; Falaschi F; Frattoni A; Perani G; Finardi G; Gazo A; Nai M; Romanini D; Bellomo G
    Kidney Int; 1994 Mar; 45(3):876-83. PubMed ID: 8196291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity.
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 May; 150(1):129-34. PubMed ID: 10781643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians.
    Cherubini A; Zuliani G; Costantini F; Pierdomenico SD; Volpato S; Mezzetti A; Mecocci P; Pezzuto S; Bregnocchi M; Fellin R; Senin U;
    J Am Geriatr Soc; 2001 May; 49(5):651-4. PubMed ID: 11380761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S; Shortal BP; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.
    Raal FJ; Areias AJ; Waisberg R; von Arb M
    Atherosclerosis; 1995 May; 115(1):9-15. PubMed ID: 7669091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.
    Girona J; Manzanares JM; Marimón F; Cabré A; Heras M; Guardiola M; Ribalta J; Masana L
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):380-7. PubMed ID: 17904830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.